K. Rufibach

Endocrine symptom assessment in women with breast cancer: what a simple “yes” means

K. Rufibach, B. Thürlimann, T. Ruhstaller, 2007, Supportive Care in Cancer.

IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN a SUBSET OF PATIENTS IN THE RANDOMISED GALLIUM TRIAL WITH PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA (MZL)

E. Hoster, W. Hiddemann, K. Rufibach, 2017 .